header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

SURVIVAL OF BIRMINGHAM HIP RESURFACING IN PATIENTS WITH FEMORAL HEAD OSTEONECROSIS

British Orthopaedic Association (BOA) 2007



Abstract

Introduction

The results of the Birmingham Hip Resurfacing (BHR) device in several series reveal that the predominant mode of failure is femoral neck fracture or femoral head collapse and that careful patient selection and precise operative technique are vital to the success of this procedure. In this report we consider the results of BHR in patients with severe arthritis secondary to femoral head AVN.

Methods

This was a single-surgeon consecutive series of BHRs with a minimum follow-up of 5 years. Fifty-nine patients with Ficat-Arlet grade III or IV femoral head AVN (66 hips) and treated with BHRs at a mean age of 43.9 years (range 19 to 67.7 years) were followed up for 5.4 to 9.6 years (mean 7.1 years). No patient died and none was lost to follow-up. Revision for any reason was the end-point and unrevised patients were assessed with Oxford hip scores. They were also reviewed clinically and with AP and lateral radiographs.

Results

There were five failures in this cohort, giving a failure rate of 7.6% and a cumulative survivorship of 86% at 9.6 years. In one further patient the femoral component has tilted into varus from further collapse of the femoral head. He is asymptomatic but knows that he will need a revision if he develops symptoms. No other patient shows clinical or radiological adverse signs.

Discussion

Several studies have shown that the results of arthroplasty are generally worse in AVN as compared to those in osteoarthritis. Reviewing the above results it appears to us that the relatively poorer cumulative survival observed in patients with a diagnosis of AVN (86%) compared to those with other diagnoses make AVN a relative contraindication to the hip resurfacing procedure.